Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Twist Bioscience Corp (TWST)
NASDAQ:TWST
Twist Bioscience (TWST) Stock Price & Analysis
832 Followers
TWST Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$14.42 - $55.26
Previous Close$53.44
Volume1.15M
Average Volume (3M)1.16M
Market Cap
$3.11B
Enterprise Value$2.89B
Total Cash (Recent Filing)$311.14M
Total Debt (Recent Filing)$91.88M
Price to Earnings (P/E)―
Beta2.94
Next Earnings
Aug 02, 2024EPS Estimate
-$0.76Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-3.35
Shares Outstanding58,225,999
10 Day Avg. Volume1,219,127
30 Day Avg. Volume1,155,783
Standard Deviation0.21
R-Squared0.20
Alpha0.00665
Financial Highlights & Ratios
Price to Book (P/B)6.58
Price to Sales (P/S)12.11
Price to Cash Flow (P/CF)-32.30
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue14.15
Enterprise Value/Gross Profit32.23
Enterprise Value/Ebitda-15.91
Forecast
1Y Price Target
$46.88Price Target Upside-16.51% Downside
Rating ConsensusModerate Buy
Number of Analyst Covering8
Twist Bioscience News
Bulls Say, Bears Say
Bulls Say
Market OpportunityThe Biosecure Act could be shaping up to be a tailwind for TWST as potential shifts in market share from competitor GenScript's US-based Life Science business could benefit TWST significantly.
Product LaunchTWST began an expanded commercial launch of its Express Genes offering, which has already received more than 1,600 orders from over 700 accounts, including more than 100 new customers.
Revenue GrowthTWST once again reported stronger than expected revenue and gross margins, leading to an upward revision in FY24 revenue guidance by $11.5 million at the midpoint.
Bears Say
EarningsBiopharma revenue is expected to be approximately $20mn, from previous guide of $24mn.
Financial PerformanceThere remains a concern around one-time orders due to seasonality and the durability of orders throughout the year.
Operational ChallengesTWST has to have two different computer systems set up in China because the government has complete oversight of its passwords and everything else.
---
Ownership Overview
11.53% Insiders
33.62% Mutual Funds
28.71% Other Institutional Investors
26.14% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
TWST FAQ
What was Twist Bioscience Corp’s price range in the past 12 months?
Twist Bioscience Corp lowest stock price was $14.42 and its highest was $55.26 in the past 12 months.
What is Twist Bioscience Corp’s market cap?
Currently, no data Available
When is Twist Bioscience Corp’s upcoming earnings report date?
Twist Bioscience Corp’s upcoming earnings report date is Aug 02, 2024 which is in 12 days.
How were Twist Bioscience Corp’s earnings last quarter?
Twist Bioscience Corp released its earnings results on May 02, 2024. The company reported -$0.79 earnings per share for the quarter, beating the consensus estimate of -$0.816 by $0.026.
Is Twist Bioscience Corp overvalued?
According to Wall Street analysts Twist Bioscience Corp’s price is currently Overvalued.
Does Twist Bioscience Corp pay dividends?
Twist Bioscience Corp does not currently pay dividends.
What is Twist Bioscience Corp’s EPS estimate?
Twist Bioscience Corp’s EPS estimate is -$0.76.
How many shares outstanding does Twist Bioscience Corp have?
Twist Bioscience Corp has 58,225,998 shares outstanding.
What happened to Twist Bioscience Corp’s price movement after its last earnings report?
Twist Bioscience Corp reported an EPS of -$0.79 in its last earnings report, beating expectations of -$0.816. Following the earnings report the stock price went up 28.741%.
Which hedge fund is a major shareholder of Twist Bioscience Corp?
Among the largest hedge funds holding Twist Bioscience Corp’s share is ARK Investment Management LLC. It holds Twist Bioscience Corp’s shares valued at 238M.
---
Twist Bioscience Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$46.88 (-16.51% Downside)
$46.88 (-16.51% Downside)
Blogger Sentiment
Bullish
TWST Sentiment 87%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Decreased
By 18.5K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Neutral
Last 7 Days ▼ 1.7%
Last 30 Days ▲ 1.6%
Last 30 Days ▲ 1.6%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
130.24%
12-Months-Change
Fundamentals
Return on Equity
-30.40%
Trailing 12-Months
Asset Growth
-17.69%
Trailing 12-Months
Company Description
Twist Bioscience Corp
Twist Bioscience Corp. develops proprietary semiconductor-based synthetic DNA manufacturing process. It produces synthetic biology tools such as genes, oligo pools, variant libraries, DNA data storage and NGS. The company also produces agriculture production as well as new applications such as in vivo diagnostics, biodetection and data storage. Twist Bioscience was founded by William Marine Banyai, Emily Marine Leproust and Bill James Peck in February 2013 and is headquartered in San Francisco, CA.
---
TWST Company Deck
---
TWST Earnings Call
Q2 2024
0:00 / 0:00
---
TWST Stock 12 Month Forecast
Average Price Target
$46.88
▼(-16.51% Downside)
Technical Analysis
Best Analysts Covering TWST
1 Year
1 Year Success Rate
7/11 ratings generated profit
1 Year Average Return
+10.45%
reiterated a buy rating 24 days ago
Copying Steven Mah's trades and holding each position for 1 Year would result in 63.64% of your transactions generating a profit, with an average return of +10.45% per trade.
---